Showing 1 posts of 1 posts found.
NICE became more restrictive in its assessment of new cancer drugs between 2007 and 2009, a new report suggests. The …
Scots neonatal innovations target hearing loss and earlier care
FDA grants De Novo authorisation to light-filtering device for migraine
Southgate opens Innovation Lab for logistics and fulfilment development
Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
Agentis Health Group acquires Clinical Pharmacist Solutions